<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IMR</journal-id>
<journal-id journal-id-type="hwp">spimr</journal-id>
<journal-id journal-id-type="nlm-ta">International Medical Research</journal-id>
<journal-title>Journal of International Medical Research</journal-title>
<issn pub-type="ppub">0300-0605</issn>
<issn pub-type="epub">1473-2300</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300060513475570</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300060513475570</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Association between vascular endothelial growth factor +936 C/T gene polymorphism and age-related macular degeneration</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Jiang</surname><given-names>Yanming</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513475570">1</xref>
<xref ref-type="aff" rid="aff2-0300060513475570">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liang</surname><given-names>Ge</given-names></name>
<xref ref-type="aff" rid="aff2-0300060513475570">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname><given-names>Liqiang</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513475570">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Jiang</surname><given-names>Jingjing</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513475570">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Du</surname><given-names>Gaiping</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513475570">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Huang</surname><given-names>Yifei</given-names></name>
<xref ref-type="aff" rid="aff1-0300060513475570">1</xref>
<xref ref-type="corresp" rid="corresp1-0300060513475570"/>
</contrib>
</contrib-group>
<aff id="aff1-0300060513475570"><label>1</label>Department of Ophthalmology, Chinese PLA General Hospital, Beijing, China</aff>
<aff id="aff2-0300060513475570"><label>2</label>Department of Ophthalmology, Chinese PLA Second Artillery General Hospital, Beijing, China</aff>
<author-notes>
<corresp id="corresp1-0300060513475570">Dr Yifei Huang, Department of Ophthalmology, Chinese PLA General Hospital, 28 Fuxing Road, Haidian District, Beijing 100853, China. Email: <email>yfeihuang@hotmail.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>41</volume>
<issue>2</issue>
<fpage>317</fpage>
<lpage>324</lpage>
<history>
<date date-type="received"><day>23</day><month>8</month><year>2012</year></date>
<date date-type="accepted"><day>2</day><month>9</month><year>2012</year></date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec>
<title>Objectives</title>
<p>The pathogenesis of age-related macular degeneration (AMD) remains unknown. Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and a target for inhibition therapy in wet AMD. This study investigated the association between the <italic>VEGF</italic> +936 C/T gene polymorphism and AMD, in a Chinese Han population.</p>
</sec>
<sec>
<title>Methods</title>
<p>Patients with AMD, and age- and sex-matched controls were enrolled. Restriction fragment length polymorphism was used to analyse the <italic>VEGF</italic> +936 polymorphism in the promoter and the 3′ untranslated region of the gene.</p>
</sec>
<sec>
<title>Results</title>
<p>The study included 200 AMD patients and 200 control subjects. There was a significantly higher prevalence of the TT genotype among AMD patients (9.0%) compared with controls (3.5%); the odds ratio for this genotype in AMD patients was 2.73 (95% confidence intervals 1.11, 6.68). There were no significant associations between any genotype and AMD subphenotypic categories (early, geographic atrophy, choroidal neovascularization).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>The present study findings suggested that the <italic>VEGF</italic> +936 TT genotype was associated with AMD among Han Chinese patients.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Age-related macular degeneration</kwd>
<kwd>gene polymorphism</kwd>
<kwd>polymerase chain reaction</kwd>
<kwd>restriction fragment length polymorphism</kwd>
<kwd>vascular endothelial growth factor</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0300060513475570" sec-type="intro"><title>Introduction</title>
<p>Age-related macular degeneration (AMD) is the most common cause of irreversible visual impairment in the developed world, in people aged ≥50 years.<sup><xref ref-type="bibr" rid="bibr1-0300060513475570">1</xref>,<xref ref-type="bibr" rid="bibr2-0300060513475570">2</xref></sup> The incidence of AMD is low in persons younger than 50 years of age (0.05%), but climbs to 11.8% in those over 80 years of age.<sup><xref ref-type="bibr" rid="bibr3-0300060513475570">3</xref></sup> Although current therapeutic options are largely limited to the late stages of the disease,<sup><xref ref-type="bibr" rid="bibr4-0300060513475570">4</xref></sup> advances in early diagnosis and major developments in treatment have substantially improved the prognosis for patients with AMD. Several risk factors for AMD (including increasing age,<sup><xref ref-type="bibr" rid="bibr5-0300060513475570">5</xref></sup> cigarette smoking,<sup><xref ref-type="bibr" rid="bibr6-0300060513475570">6</xref></sup> higher body mass index,<sup><xref ref-type="bibr" rid="bibr7-0300060513475570">7</xref>,<xref ref-type="bibr" rid="bibr8-0300060513475570">8</xref></sup> sun exposure,<sup><xref ref-type="bibr" rid="bibr9-0300060513475570">9</xref></sup> arterial hypertension<sup><xref ref-type="bibr" rid="bibr10-0300060513475570">10</xref></sup> and nutritional factors<sup><xref ref-type="bibr" rid="bibr11-0300060513475570">11</xref></sup>) have been identified. Moreover, a genetic component to AMD has been established, based on familial aggregation and linkage studies.<sup><xref ref-type="bibr" rid="bibr12-0300060513475570">12</xref>–<xref ref-type="bibr" rid="bibr14-0300060513475570">14</xref></sup></p>
<p>Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis and a target for inhibition therapy in wet AMD;<sup><xref ref-type="bibr" rid="bibr15-0300060513475570">15</xref></sup> it has also been found to play a key role in choroidal neovascularization.<sup><xref ref-type="bibr" rid="bibr16-0300060513475570">16</xref></sup> Current treatments that inhibit VEGF activity are effective in improving vision in ∼40% of eyes with neovascular AMD.<sup><xref ref-type="bibr" rid="bibr17-0300060513475570">17</xref></sup> The human <italic>VEGF</italic> gene is located on chromosome 6p21.3 and is organized into eight exons and seven introns, with the coding region spanning ∼14 kb.<sup><xref ref-type="bibr" rid="bibr18-0300060513475570">18</xref>–<xref ref-type="bibr" rid="bibr21-0300060513475570">21</xref></sup> Several single-nucleotide polymorphisms (SNPs) in the <italic>VEGF</italic> gene affect its expression.<sup><xref ref-type="bibr" rid="bibr22-0300060513475570">22</xref>–<xref ref-type="bibr" rid="bibr25-0300060513475570">25</xref></sup> One of these, the +936 C/T polymorphism in the promoter and 3<italic>′</italic> untranslated region (UTR) of the <italic>VEGF</italic> gene, affects VEGF plasma levels; carriers of the <italic>VEGF</italic> 936T allele have significantly reduced VEGF plasma levels.<sup><xref ref-type="bibr" rid="bibr26-0300060513475570">26</xref>–<xref ref-type="bibr" rid="bibr28-0300060513475570">28</xref></sup></p>
<p>Although some studies have evaluated the role of polymorphisms in the <italic>VEGF</italic> gene in AMD, relatively little about it remains known.<sup><xref ref-type="bibr" rid="bibr15-0300060513475570">15</xref>,<xref ref-type="bibr" rid="bibr26-0300060513475570">26</xref>,<xref ref-type="bibr" rid="bibr29-0300060513475570">29</xref>–<xref ref-type="bibr" rid="bibr37-0300060513475570">37</xref></sup> The present study investigated the association between the <italic>VEGF</italic> +936 C/T gene polymorphism and AMD in a Chinese Han population.</p>
</sec>
<sec id="sec2-0300060513475570" sec-type="methods"><title>Patients and methods</title>
<sec id="sec3-0300060513475570"><title>Study Population</title>
<p>Between January 2010 and January 2012, consecutive patients with AMD, and age- and sex-matched controls, attending the Department of Ophthalmology at the Chinese PLA General Hospital, Beijing, China, were enrolled in this population-based control study. The controls were randomly selected from healthy individuals (using a random-number table) who underwent routine physical examination during the same time period as the patients. All participants were of Han Chinese origin and came from the same geographic region, and all underwent complete ophthalmological examination (including visual acuity measurement, slit-lamp biomoscopic examination and dilated fundus examination). Patients with AMD underwent colour fundus photography, fluorescein angiography and optical coherence tomography.</p>
<p>Patients with AMD were diagnosed according to the International Classification System<sup><xref ref-type="bibr" rid="bibr38-0300060513475570">38</xref></sup> and were subdivided into one of three phenotype categories: early AMD (stages 1a, 1b, 2a, 2b and 3); geographic atrophy (stage 4ga); exudative AMD (choroidal neovascularization; stage 4cnv). Patients with AMD had to have at least one soft drusen &gt;0.125 µm in one eye to be eligible for study inclusion. Participants with a family history of AMD or ocular diseases that might simulate AMD or preclude its diagnosis (namely, previous laser photocoagulation, cryopexy, media opacity or inflammatory diseases) were excluded from the study.</p>
<p>The Institutional Review Board of the Chinese PLA General Hospital approved the study and written informed consent was obtained from all participants. All procedures adhered to the tenets of the Declaration of Helsinki.</p>
</sec>
<sec id="sec4-0300060513475570"><title>DNA Extraction and Genotyping</title>
<p>Genomic DNA was isolated from 3–5 ml ethylenediaminetetra-acetic acid (20 g/l) or 4% sodium citrate (citrate 136, sodium 408 mmol/l) anticoagulated venous blood, using the QIAamp® Blood Mini Kit (QIAGEN GmbH, Hilden, Germany), according to the manufacturer’s instructions. Samples were stored at 4°C until analysis. PCR reactions were carried out in a 20-µl reaction volume containing 100 µg genomic DNA, 25 pmol/l each primer, 0.2 mmol/l deoxyuceotide triphosphate, 10 mmol/l Tris–HCl (pH 8.3), 50 mmol/l KCl, 1.5 mmol/l MgCl<sub>2</sub>, and 1 U of <italic>Taq</italic> polymerase (Takara Shuzo, Otsu, Japan). The following primers were used: forward 5<italic>′</italic>- AGGAAGAGGGACTCTGCGCAGAGC-3<italic>′</italic> and reverse 5<italic>′</italic>- TAA ATG TATGTATGTGGGTGGGTGTGTCTACAGG-3<italic>′</italic>. The PCR cycle conditions consisted of an initial denaturation step at 94°C for 5 min, followed by 35 cycles of 30 s at 94°C, 30 s at 62°C, 30 s at 72°C, and a final elongation step at 72°C for 10 min, using a GeneAmp®-PCR System 9700 thermal cycler (Applied Biosystems®, Foster City, CA, USA).</p>
<p>The <italic>VEGF</italic> +936 C/T polymorphism was genotyped using restriction fragment length polymorphism. Briefly, PCR products were digested overnight at 37°C with NlaIII (30 U of enzyme/µg of DNA) (New England Biolabs, Beverly, MA). Digested PCR products were then resolved on a 3% agarose gel and stained with ethidium bromide for visualization under UV light. The <italic>VEGF</italic> +936T allele was cut into two fragments of 122 and 86 base pairs, whereas the <italic>VEGF</italic> +936C allele remained uncut, with a length of 208 base pairs.</p>
</sec>
<sec id="sec5-0300060513475570"><title>Statistical Analyses</title>
<p>All analyses were performed using Predictive Analytics Software version 18.0 (SPSS Inc., Chicago, IL, USA) for Windows®. Comparison of continuous or categorical variables between the AMD group and controls were compared using a two-sided Student’s <italic>t</italic>-test or χ<sup>2</sup>-test, respectively. Comparison of <italic>VEGF</italic> +936 C/T genotype frequencies between AMD and controls was assessed by Pearson's χ<sup>2</sup>-test, and odds ratios (ORs) and 95% confidence intervals (CI) were calculated. The association between the AMD phenotype and genotype was examined using a logistic regression model, and the ORs and 95% CIs were calculated. Genotype distribution was tested for Hardy–Weinberg equilibrium using the χ<sup>2</sup>-test. A <italic>P</italic>-value &lt;0.05 was considered to be statistically significant.</p>
</sec>
</sec>
<sec id="sec6-0300060513475570" sec-type="results"><title>Results</title>
<p>Characteristics of the 200 patients with AMD and 200 control subjects are shown in <xref ref-type="table" rid="table1-0300060513475570">Table 1</xref>. There were no statistically significant differences in mean age, sex distribution, smoking status, body mass index, hypertension, hyperlipidaemia, diabetes or cardiovascular disease between the two groups. Of the 200 patients with AMD, roughly half had choroidal neovascularization, with a further quarter each having early AMD or geographic atrophy.
<table-wrap id="table1-0300060513475570" position="float"><label>Table 1.</label><caption><p>Characteristics of patients with age-related macular degeneration (AMD), and age- and sex-matched healthy controls, in a study of vascular endothelial growth factor (<italic>VEGF</italic>) gene +936 C/T gene polymorphis.</p></caption>
<graphic alternate-form-of="table1-0300060513475570" xlink:href="10.1177_0300060513475570-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Parameter</th>
<th>AMD patients<sup><xref ref-type="table-fn" rid="table-fn2-0300060513475570">a</xref></sup> <italic>n</italic> = 200</th>
<th>Controls<sup><xref ref-type="table-fn" rid="table-fn2-0300060513475570">a</xref></sup> <italic>n</italic> = 200</th>
</tr></thead>
<tbody align="left">
<tr>
<td>Age, years</td>
<td>70.6 ± 8.4</td>
<td>70.5 ± 8.3</td>
</tr>
<tr>
<td>Sex</td>
<td/>
<td/>
</tr>
<tr>
<td> Male</td>
<td>90 (45.0)</td>
<td>94 (47.0)</td>
</tr>
<tr>
<td> Female</td>
<td>110 (55.0)</td>
<td>106 (53.0)</td>
</tr>
<tr>
<td>Smoking status</td>
<td/>
<td/>
</tr>
<tr>
<td> Never</td>
<td>119 (59.5)</td>
<td>122 (61.0)</td>
</tr>
<tr>
<td> Ever</td>
<td>81 (40.5)</td>
<td>78 (39.0)</td>
</tr>
<tr>
<td>Body mass index, kg/m<sup>2</sup></td>
<td>23.9 ± 0.8</td>
<td>23.8 ± 0.7</td>
</tr>
<tr>
<td>Hypertension</td>
<td>97 (48.5)</td>
<td>95 (47.5)</td>
</tr>
<tr>
<td>Hyperlipidaemia</td>
<td>41 (20.5)</td>
<td>38 (19.0)</td>
</tr>
<tr>
<td>Diabetes</td>
<td>17 (8.5)</td>
<td>18 (9.0)</td>
</tr>
<tr>
<td>Cardiovascular disease</td>
<td>28 (14.0)</td>
<td>27 (13.5)</td>
</tr>
<tr>
<td>AMD phenotypic categories</td>
<td/>
<td/>
</tr>
<tr>
<td> Early</td>
<td>52 (26.0)</td>
<td>N/A</td>
</tr>
<tr>
<td> Geographic atrophy</td>
<td>49 (24.5)</td>
<td>N/A</td>
</tr>
<tr>
<td> Choroidal neovascularization</td>
<td>99 (49.5)</td>
<td>N/A</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300060513475570"><p>Data presented as <italic>n</italic> (%) patients or mean ± SD.</p></fn>
<fn id="table-fn2-0300060513475570"><label>a</label><p>No statistically significantly differences (<italic>P</italic> ≥ 0.05); two-sided Student’s <italic>t</italic>-test or χ<sup>2</sup>-test.</p></fn>
<fn id="table-fn3-0300060513475570"><p>N/A, not applicable.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>The prevalence of the <italic>VEGF</italic> +936 T/T genotype was 9.0% among patients with AMD compared with 3.5% among controls (OR: 2.73 [95% CI 1.11, 6.68]; <xref ref-type="table" rid="table2-0300060513475570">Table 2</xref>). Genotype and allele frequencies were in Hardy–Weinberg equilibrium in both groups. There were no significant associations between genotypes and AMD phenotypic categories (<xref ref-type="table" rid="table3-0300060513475570">Table 3</xref>).
<table-wrap id="table2-0300060513475570" position="float"><label>Table 2.</label><caption><p>Prevalence of the vascular endothelial growth factor (<italic>VEGF</italic>) +936 C/T gene polymorphism among patients with age-related macular degeneration (AMD), and age- and sex-matched control.</p></caption>
<graphic alternate-form-of="table2-0300060513475570" xlink:href="10.1177_0300060513475570-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Genotype</th>
<th>AMD patients <italic>n</italic> = 200</th>
<th>Controls <italic>n</italic> = 200</th>
<th>OR (95% CI)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>CC</td>
<td>132 (66.0)</td>
<td>138 (69.0)</td>
<td>0.87 (0.57, 1.33)</td>
</tr>
<tr>
<td>CT</td>
<td>50 (25.0)</td>
<td>55 (27.5)</td>
<td>0.88 (0.56, 1.37)</td>
</tr>
<tr>
<td>TT</td>
<td>18 (9.0)</td>
<td>7 (3.5)</td>
<td>2.73 (1.11, 6.68)</td>
</tr>
<tr>
<td>C allele frequency</td>
<td>314 (78.5)</td>
<td>331 (82.8)</td>
<td>0.76 (0.54, 1.08)</td>
</tr>
<tr>
<td>T allele frequency</td>
<td>86 (21.5)</td>
<td>69 (17.3)</td>
<td>1.31 (0.92, 1.87)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-0300060513475570"><p>Data presented as <italic>n</italic> (%) of patients or mean ± SD.</p></fn>
<fn id="table-fn5-0300060513475570"><p>Pearson's χ<sup>2</sup>-test: OR, odds ratio; CI, confidence interval; calculated using logistic regression analysis.</p></fn></table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0300060513475570" position="float"><label>Table 3.</label><caption><p>Stratification analysis of vascular endothelial growth factor (<italic>VEGF</italic>) +936 C/T genotype frequency among patients with age-related macular degeneration (AMD.</p></caption>
<graphic alternate-form-of="table3-0300060513475570" xlink:href="10.1177_0300060513475570-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="2">Category</th>
<th rowspan="2">Cases</th>
<th/>
<th>CC<sup><xref ref-type="table-fn" rid="table-fn7-0300060513475570">a</xref></sup></th>
<th/>
<th>CT<sup><xref ref-type="table-fn" rid="table-fn7-0300060513475570">a</xref></sup></th>
<th/>
<th>TT<sup><xref ref-type="table-fn" rid="table-fn7-0300060513475570">a</xref></sup></th>
</tr>
<tr><th><italic>n</italic> (%)</th>
<th>OR (95% CI)</th>
<th><italic>n</italic> (%)</th>
<th>OR (95% CI)</th>
<th><italic>n</italic> (%)</th>
<th>OR (95% CI)</th>
</tr></thead>
<tbody align="left">
<tr>
<td>AMD genotype</td>
<td>200</td>
<td>132 (66.0)</td>
<td>1 (Reference)</td>
<td>50 (25.0)</td>
<td>1 (Reference)</td>
<td>18 (9.0)</td>
<td>1 (Reference)</td>
</tr>
<tr>
<td>AMD phenotype</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td> Early</td>
<td>52</td>
<td>34 (65.4)</td>
<td>0.99 (0.61, 1.61)</td>
<td>12 (23.1)</td>
<td>0.92 (0.46, 1.86)</td>
<td>6 (11.5)</td>
<td>1.28 (0.49, 3.39)</td>
</tr>
<tr>
<td> Geographic atrophy</td>
<td>49</td>
<td>32 (65.3)</td>
<td>0.99 (0.60, 1.63)</td>
<td>13 (26.5)</td>
<td>1.06 (0.54, 2.11)</td>
<td>4 (8.2)</td>
<td>0.91 (0.29, 2.80)</td>
</tr>
<tr>
<td> Choroidal   neovascularization</td>
<td>99</td>
<td>66 (66.7)</td>
<td>1.01 (0.69, 1.48)</td>
<td>25 (25.3)</td>
<td>1.01 (0.59, 1.73)</td>
<td>8 (8.1)</td>
<td>0.90 (0.38, 2.14)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-0300060513475570"><p>OR, odds ratio; CI, confidence interval; calculated using logistic regression analysis.</p></fn>
<fn id="table-fn7-0300060513475570"><label>a</label><p>No statistically significantly differences (<italic>P</italic> ≥ 0.05).</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec7-0300060513475570" sec-type="discussion"><title>Discussion</title>
<p>The present study demonstrated that the <italic>VEGF</italic> +936 TT genotype was associated with AMD in Han Chinese patients. There were no significant associations between genotype and AMD phenotype.</p>
<p>The <italic>VEGF</italic> +936 C/T gene polymorphism is associated with many other diseases; for example, in Han Chinese populations, the <italic>VEGF</italic> +936 TT genotype has been associated with a higher risk of glioma<sup><xref ref-type="bibr" rid="bibr39-0300060513475570">39</xref></sup> and with acute respiratory distress syndrome.<sup><xref ref-type="bibr" rid="bibr40-0300060513475570">40</xref></sup> A meta-analysis found an association between the <italic>VEGF</italic> +936C allele and a decreased risk of oral cancer,<sup><xref ref-type="bibr" rid="bibr41-0300060513475570">41</xref></sup> which was in contrast to the findings of a case–control study that suggested that the <italic>VEGF</italic> +936C allele was associated with vascular invasion in oral squamous cell carcinoma.<sup><xref ref-type="bibr" rid="bibr42-0300060513475570">42</xref></sup> A further case–control study suggested that the <italic>VEGF</italic> +936 C/T polymorphism might be a genetic determinant for colon cancer in Koreans.<sup><xref ref-type="bibr" rid="bibr43-0300060513475570">43</xref></sup> The <italic>VEGF</italic> +936T allele has been found to be associated with an increased risk of stage III–IV endometriosis in a Japanese population,<sup><xref ref-type="bibr" rid="bibr44-0300060513475570">44</xref></sup> and a decreased risk of breast cancer.<sup><xref ref-type="bibr" rid="bibr45-0300060513475570">45</xref></sup></p>
<p>There have been previous reports of genetic polymorphisms associated with AMD, including polymorphism of the heme oxygenase-1 and -2 genes,<sup><xref ref-type="bibr" rid="bibr46-0300060513475570">46</xref></sup> mitochondrial DNA polymorphism A4917G,<sup><xref ref-type="bibr" rid="bibr47-0300060513475570">47</xref></sup> complement factor H gene Y402H polymorphism<sup><xref ref-type="bibr" rid="bibr48-0300060513475570">48</xref></sup> <italic>C3</italic> R102G polymorphism<sup><xref ref-type="bibr" rid="bibr49-0300060513475570">49</xref></sup> and high-temperature requirement A-1 LOC387715 gene A69S.<sup><xref ref-type="bibr" rid="bibr14-0300060513475570">14</xref></sup> Further associations have been found through meta-analyses, including the <italic>LOC387715/HTRA1</italic> gene,<sup><xref ref-type="bibr" rid="bibr50-0300060513475570">50</xref></sup> the human high-temperature requirement A-1 gene -512 G/A<sup><xref ref-type="bibr" rid="bibr51-0300060513475570">51</xref></sup> and rs11200638 in the promoter of <italic>HTRA1</italic> gene.<sup><xref ref-type="bibr" rid="bibr52-0300060513475570">52</xref></sup></p>
<p>A systematic review and meta-analysis of eight studies found strong evidence for an association between complement factor H and AMD, and indicated a multiplicative model (with each C allele increasing the odds of AMD by approximately 2.5-fold).<sup><xref ref-type="bibr" rid="bibr52-0300060513475570">52</xref></sup> A meta-analysis from 15 case–control studies (8905 participants) indicated strong protective effects against AMD for the variant alleles of four SNPs in the <italic>CFB/C2</italic> gene (rs9332739, rs547154, rs4151667 and rs641153).<sup><xref ref-type="bibr" rid="bibr53-0300060513475570">53</xref></sup> A meta-analysis of reported studies (<italic>n</italic> = 2600 participants) showed that the 32W variant of complement factor B was also associated with protection against AMD.<sup><xref ref-type="bibr" rid="bibr54-0300060513475570">54</xref></sup></p>
<p>Limitations of the present study included the fact that it was a hospital-based, case–control study; thus, selection bias may have occurred and the participants may not have been representative of the general population. Only one SNP in the <italic>VEGF</italic> gene was examined, and the precise significance of the <italic>VEGF</italic> +936 C/T gene polymorphism in AMD remains unclear.</p>
<p>In conclusion, findings of this study indicate that the <italic>VEGF</italic> +936 TT genotype is found more frequently among Han Chinese patients with AMD than among control subjects. Further studies are needed to confirm this finding in larger groups of patients.</p>
</sec>
</body>
<back>
<sec id="sec8-0300060513475570"><title>Declaration of Conflicting Interest</title>
<p>The authors declare that there are no conflicts of interest.</p>
</sec>
<sec id="sec9-0300060513475570"><title>Funding</title>
<p>This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors<bold>.</bold></p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-0300060513475570"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Stratton</surname><given-names>C</given-names></name><name><surname>Francis</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Toll-like receptor 3 and geographic atrophy in age-related macular degeneration</article-title>. <source>N Engl J Med</source> <year>2008</year>; <volume>359</volume>: <fpage>1456</fpage>–<lpage>1463</lpage>.</citation></ref>
<ref id="bibr2-0300060513475570"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jager</surname><given-names>RD</given-names></name><name><surname>Mieler</surname><given-names>WF</given-names></name><name><surname>Miller</surname><given-names>JW</given-names></name></person-group>. <article-title>Age-related macular degeneration</article-title>. <source>N Engl J Med</source> <year>2008</year>; <volume>358</volume>: <fpage>2606</fpage>–<lpage>2617</lpage>.</citation></ref>
<ref id="bibr3-0300060513475570"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>PT</given-names></name></person-group>. <article-title>Age-related macular degeneration</article-title>. <source>N Engl J Med</source> <year>2006</year>; <volume>355</volume>: <fpage>1474</fpage>–<lpage>1485</lpage>.</citation></ref>
<ref id="bibr4-0300060513475570"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaufman</surname><given-names>SR</given-names></name></person-group>. <article-title>Developments in age-related macular degeneration: diagnosis and treatment</article-title>. <source>Geriatrics</source> <year>2009</year>; <volume>64</volume>: <fpage>16</fpage>–<lpage>19</lpage>.</citation></ref>
<ref id="bibr5-0300060513475570"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>J</given-names></name><name><surname>Wormald</surname><given-names>R</given-names></name></person-group>. <article-title>Is the incidence of registrable age-related macular degeneration increasing?</article-title> <source>Br J Ophthalmol</source> <year>1996</year>; <volume>80</volume>: <fpage>9</fpage>–<lpage>14</lpage>.</citation></ref>
<ref id="bibr6-0300060513475570"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>DeBlack</surname><given-names>SS</given-names></name></person-group>. <article-title>Cigarette smoking as a risk factor for cataract and age-related macular degeneration: a review of the literature</article-title>. <source>Optometry</source> <year>2003</year>; <volume>74</volume>: <fpage>99</fpage>–<lpage>110</lpage>.</citation></ref>
<ref id="bibr7-0300060513475570"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seddon</surname><given-names>JM</given-names></name><name><surname>Reynolds</surname><given-names>R</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name></person-group>. <article-title>Associations of smoking, body mass index, dietary lutein, and the LIPC gene variant rs10468017 with advanced age-related macular degeneration</article-title>. <source>Mol Vis</source> <year>2010</year>; <volume>16</volume>: <fpage>2412</fpage>–<lpage>2424</lpage>.</citation></ref>
<ref id="bibr8-0300060513475570"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname><given-names>PJ</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Schultz</surname><given-names>DW</given-names></name><etal/></person-group>. <article-title>The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration</article-title>. <source>Hum Hered</source> <year>2007</year>; <volume>63</volume>: <fpage>212</fpage>–<lpage>218</lpage>.</citation></ref>
<ref id="bibr9-0300060513475570"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vojnikovic</surname><given-names>B</given-names></name><name><surname>Micovic</surname><given-names>V</given-names></name><name><surname>Coklo</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Sun exposure and visual field damage among children on the Adriatic Island Rab–possible initial risk factor in development of age-related macular degeneration</article-title>. <source>Coll Antropol</source> <year>2009</year>; <volume>33</volume>: <fpage>747</fpage>–<lpage>749</lpage>.</citation></ref>
<ref id="bibr10-0300060513475570"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metelitsina</surname><given-names>TI</given-names></name><name><surname>Grunwald</surname><given-names>JE</given-names></name><name><surname>DuPont</surname><given-names>JC</given-names></name><etal/></person-group>. <article-title>Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration</article-title>. <source>Br J Ophthalmol</source> <year>2006</year>; <volume>90</volume>: <fpage>342</fpage>–<lpage>346</lpage>.</citation></ref>
<ref id="bibr11-0300060513475570"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JJ</given-names></name><name><surname>Rochtchina</surname><given-names>E</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Combined effects of complement factor H genotypes, fish consumption, and inflammatory markers on long-term risk for age-related macular degeneration in a cohort</article-title>. <source>Am J Epidemiol</source> <year>2009</year>; <volume>169</volume>: <fpage>633</fpage>–<lpage>641</lpage>.</citation></ref>
<ref id="bibr12-0300060513475570"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shahid</surname><given-names>H</given-names></name><name><surname>Khan</surname><given-names>JC</given-names></name><name><surname>Cipriani</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Age-related macular degeneration: the importance of family history as a risk factor</article-title>. <source>Br J Ophthalmol</source> <year>2012</year>; <volume>96</volume>: <fpage>427</fpage>–<lpage>431</lpage>.</citation></ref>
<ref id="bibr13-0300060513475570"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Silvestri</surname><given-names>G</given-names></name><name><surname>Johnston</surname><given-names>PB</given-names></name><name><surname>Hughes</surname><given-names>AE</given-names></name></person-group>. <article-title>Is genetic predisposition an important risk factor in age-related macular degeneration?</article-title> <source>Eye (Lond)</source> <year>1994</year>; <volume>8</volume>: <fpage>564</fpage>–<lpage>568</lpage>.</citation></ref>
<ref id="bibr14-0300060513475570"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soysal</surname><given-names>Y</given-names></name><name><surname>Inan</surname><given-names>UU</given-names></name><name><surname>Kusbeci</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Age-related macular degeneration and association of CFH Y402H and LOC387715 A69S polymorphisms in a Turkish population</article-title>. <source>DNA Cell Biol</source> <year>2012</year>; <volume>31</volume>: <fpage>323</fpage>–<lpage>330</lpage>.</citation></ref>
<ref id="bibr15-0300060513475570"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boekhoorn</surname><given-names>SS</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>Uitterlinden</surname><given-names>AG</given-names></name><etal/></person-group>. <article-title>Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study</article-title>. <source>Ophthalmology</source> <year>2008</year>; <volume>115</volume>: <fpage>1899</fpage>–<lpage>1903</lpage>.</citation></ref>
<ref id="bibr16-0300060513475570"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Witmer</surname><given-names>AN</given-names></name><name><surname>Vrensen</surname><given-names>GF</given-names></name><name><surname>Van Noorden</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factors and angiogenesis in eye disease</article-title>. <source>Prog Retin Eye Res</source> <year>2003</year>; <volume>22</volume>: <fpage>1</fpage>–<lpage>29</lpage>.</citation></ref>
<ref id="bibr17-0300060513475570"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oishi</surname><given-names>A</given-names></name><name><surname>Mandai</surname><given-names>M</given-names></name><name><surname>Nishida</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Remission and dropout rate of anti-VEGF therapy for age-related macular degeneration</article-title>. <source>Eur J Ophthalmol</source> <year>2011</year>; <volume>21</volume>: <fpage>777</fpage>–<lpage>782</lpage>.</citation></ref>
<ref id="bibr18-0300060513475570"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vincenti</surname><given-names>V</given-names></name><name><surname>Cassano</surname><given-names>C</given-names></name><name><surname>Rocchi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3</article-title>. <source>Circulation</source> <year>1996</year>; <volume>93</volume>: <fpage>1493</fpage>–<lpage>1495</lpage>.</citation></ref>
<ref id="bibr19-0300060513475570"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>N</given-names></name></person-group>. <article-title>Molecular and biological properties of vascular endothelial growth factor</article-title>. <source>J Mol Med (Berl)</source> <year>1999</year>; <volume>77</volume>: <fpage>527</fpage>–<lpage>543</lpage>.</citation></ref>
<ref id="bibr20-0300060513475570"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>Le Couter</surname><given-names>J</given-names></name></person-group>. <article-title>The biology of VEGF and its receptors</article-title>. <source>Nat Med</source> <year>2003</year>; <volume>9</volume>: <fpage>669</fpage>–<lpage>676</lpage>.</citation></ref>
<ref id="bibr21-0300060513475570"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>FM</given-names></name><name><surname>Martins-Oliveira</surname><given-names>A</given-names></name><name><surname>Speciali</surname><given-names>JG</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor genetic polymorphisms and haplotypes in women with migraine</article-title>. <source>DNA Cell Biol</source> <year>2010</year>; <volume>29</volume>: <fpage>357</fpage>–<lpage>362</lpage>.</citation></ref>
<ref id="bibr22-0300060513475570"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belo</surname><given-names>VA</given-names></name><name><surname>Souza-Costa</surname><given-names>DC</given-names></name><name><surname>Luizon</surname><given-names>MR</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor haplotypes associated with childhood obesity</article-title>. <source>DNA Cell Biol</source> <year>2011</year>; <volume>30</volume>: <fpage>709</fpage>–<lpage>714</lpage>.</citation></ref>
<ref id="bibr23-0300060513475570"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Pooled-analysis of the associations between three polymorphisms in the VEGF gene and age-related macular degeneration</article-title>. <source>Mol Biol Rep</source> <year>2012</year>; <volume>39</volume>: <fpage>6547</fpage>–<lpage>6553</lpage>.</citation></ref>
<ref id="bibr24-0300060513475570"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>The vascular endothelial growth factor-2549 insertion/deletion polymorphism is not associated with susceptibility to hepatocellular carcinoma in Chinese</article-title>. <source>DNA Cell Biol</source> <year>2010</year>; <volume>29</volume>: <fpage>393</fpage>–<lpage>396</lpage>.</citation></ref>
<ref id="bibr25-0300060513475570"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mittal</surname><given-names>RD</given-names></name><name><surname>Srivastava</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Association of common variants of vascular endothelial growth factor and interleukin-18 genes with allograft survival in renal transplant recipients of North India</article-title>. <source>DNA Cell Biol</source> <year>2011</year>; <volume>30</volume>: <fpage>309</fpage>–<lpage>315</lpage>.</citation></ref>
<ref id="bibr26-0300060513475570"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor gene polymorphisms and risk of neovascular age-related macular degeneration in a Chinese cohort</article-title>. <source>Ophthalmic Res</source> <year>2011</year>; <volume>45</volume>: <fpage>142</fpage>–<lpage>148</lpage>.</citation></ref>
<ref id="bibr27-0300060513475570"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ajaz</surname><given-names>S</given-names></name><name><surname>Khaliq</surname><given-names>S</given-names></name><name><surname>Abid</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma</article-title>. <source>Genet Test Mol Biomarkers</source> <year>2011</year>; <volume>15</volume>: <fpage>653</fpage>–<lpage>657</lpage>.</citation></ref>
<ref id="bibr28-0300060513475570"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Association of vascular endothelial growth factor -2578C/A gene polymorphism in Chinese patients with colon cancer</article-title>. <source>Genet Test Mol Biomarkers</source> <year>2011</year>; <volume>15</volume>: <fpage>117</fpage>–<lpage>121</lpage>.</citation></ref>
<ref id="bibr29-0300060513475570"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname><given-names>LN</given-names></name><name><surname>Melilo-Carolino</surname><given-names>R</given-names></name><name><surname>Veloso</surname><given-names>CE</given-names></name><etal/></person-group>. <article-title>Homozygosity for the +674C&gt;T polymorphism on VEGF gene is associated with age-related macular degeneration in a Brazilian cohort</article-title>. <source>Graefes Arch Clin Exp Ophthalmol</source> <year>2012</year>; <volume>250</volume>: <fpage>185</fpage>–<lpage>189</lpage>.</citation></ref>
<ref id="bibr30-0300060513475570"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakata</surname><given-names>I</given-names></name><name><surname>Yamashiro</surname><given-names>K</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration</article-title>. <source>Jpn J Ophthalmol</source> <year>2011</year>; <volume>55</volume>: <fpage>435</fpage>–<lpage>443</lpage>.</citation></ref>
<ref id="bibr31-0300060513475570"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galan</surname><given-names>A</given-names></name><name><surname>Ferlin</surname><given-names>A</given-names></name><name><surname>Caretti</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor</article-title>. <source>Ophthalmology</source> <year>2010</year>; <volume>117</volume>: <fpage>1769</fpage>–<lpage>1774</lpage>.</citation></ref>
<ref id="bibr32-0300060513475570"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szaflik</surname><given-names>JP</given-names></name><name><surname>Blasiak</surname><given-names>J</given-names></name><name><surname>Krzyanowska</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration</article-title>. <source>Klin Oczna</source> <year>2009</year>; <volume>111</volume>: <fpage>125</fpage>–<lpage>127</lpage>.</citation></ref>
<ref id="bibr33-0300060513475570"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janik-Papis</surname><given-names>K</given-names></name><name><surname>Zaras</surname><given-names>M</given-names></name><name><surname>Krzyzanowska</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Association between vascular endothelial growth factor gene polymorphisms and age-related macular degeneration in a Polish population</article-title>. <source>Exp Mol Pathol</source> <year>2009</year>; <volume>87</volume>: <fpage>234</fpage>–<lpage>238</lpage>.</citation></ref>
<ref id="bibr34-0300060513475570"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>AM</given-names></name><name><surname>Lee</surname><given-names>AY</given-names></name><name><surname>Kulkarni</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Polymorphisms in the VEGFA and VEGFR-2 genes and neovascular age-related macular degeneration</article-title>. <source>Mol Vis</source> <year>2009</year>; <volume>15</volume>: <fpage>2710</fpage>–<lpage>2719</lpage>.</citation></ref>
<ref id="bibr35-0300060513475570"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>JM</given-names></name><name><surname>Wan</surname><given-names>L</given-names></name><name><surname>Tsai</surname><given-names>YY</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration</article-title>. <source>Am J Ophthalmol</source> <year>2008</year>; <volume>145</volume>: <fpage>1045</fpage>–<lpage>1051</lpage>.</citation></ref>
<ref id="bibr36-0300060513475570"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>AJ</given-names></name><name><surname>Islam</surname><given-names>FM</given-names></name><name><surname>Guymer</surname><given-names>RH</given-names></name><etal/></person-group>. <article-title>A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration</article-title>. <source>Mol Vis</source> <year>2007</year>; <volume>13</volume>: <fpage>2148</fpage>–<lpage>2152</lpage>.</citation></ref>
<ref id="bibr37-0300060513475570"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Churchill</surname><given-names>AJ</given-names></name><name><surname>Carter</surname><given-names>JG</given-names></name><name><surname>Lovell</surname><given-names>HC</given-names></name><etal/></person-group>. <article-title>VEGF polymorphisms are associated with neovascular age-related macular degeneration</article-title>. <source>Hum Mol Genet</source> <year>2006</year>; <volume>15</volume>: <fpage>2955</fpage>–<lpage>2961</lpage>.</citation></ref>
<ref id="bibr38-0300060513475570"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bird</surname><given-names>AC</given-names></name><name><surname>Bressler</surname><given-names>NM</given-names></name><name><surname>Bressler</surname><given-names>SB</given-names></name><etal/></person-group>. <article-title>An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group</article-title>. <source>Surv Ophthalmol</source> <year>1995</year>; <volume>39</volume>: <fpage>367</fpage>–<lpage>374</lpage>.</citation></ref>
<ref id="bibr39-0300060513475570"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Guo</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor +936 C/T gene polymorphism and glioma risk in a Chinese Han population</article-title>. <source>Genet Test Mol Biomarkers</source> <year>2011</year>; <volume>15</volume>: <fpage>103</fpage>–<lpage>106</lpage>.</citation></ref>
<ref id="bibr40-0300060513475570"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Cao</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Association between vascular endothelial growth factor +936 genotype and acute respiratory distress syndrome in a Chinese population</article-title>. <source>Genet Test Mol Biomarkers</source> <year>2011</year>; <volume>15</volume>: <fpage>737</fpage>–<lpage>740</lpage>.</citation></ref>
<ref id="bibr41-0300060513475570"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>C</given-names></name><name><surname>Fang</surname><given-names>JJ</given-names></name><name><surname>Ying</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor +936 C/T and +405G/C polymorphisms and cancer risk: a meta-analysis</article-title>. <source>Arch Med Res</source> <year>2010</year>; <volume>41</volume>: <fpage>548</fpage>–<lpage>557</lpage>.</citation></ref>
<ref id="bibr42-0300060513475570"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>CY</given-names></name><name><surname>Chang</surname><given-names>CS</given-names></name><name><surname>Liu</surname><given-names>CJ</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma</article-title>. <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source> <year>2008</year>; <volume>106</volume>: <fpage>79</fpage>–<lpage>84</lpage>.</citation></ref>
<ref id="bibr43-0300060513475570"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>SJ</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kang</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C&gt;T) gene and colon cancer in Korea</article-title>. <source>Anticancer Res</source> <year>2008</year>; <volume>28</volume>: <fpage>1271</fpage>–<lpage>1276</lpage>.</citation></ref>
<ref id="bibr44-0300060513475570"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikuhashi</surname><given-names>Y</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Kennedy</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Vascular endothelial growth factor +936 C/T polymorphism is associated with an increased risk of endometriosis in a Japanese population</article-title>. <source>Acta Obstet Gynecol Scand</source> <year>2007</year>; <volume>86</volume>: <fpage>1352</fpage>–<lpage>1358</lpage>.</citation></ref>
<ref id="bibr45-0300060513475570"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krippl</surname><given-names>P</given-names></name><name><surname>Langsenlehner</surname><given-names>U</given-names></name><name><surname>Renner</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk</article-title>. <source>Int J Cancer</source> <year>2003</year>; <volume>106</volume>: <fpage>468</fpage>–<lpage>471</lpage>.</citation></ref>
<ref id="bibr46-0300060513475570"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Synowiec</surname><given-names>E</given-names></name><name><surname>Szaflik</surname><given-names>J</given-names></name><name><surname>Chmielewska</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>An association between polymorphism of the heme oxygenase-1 and -2 genes and age-related macular degeneration</article-title>. <source>Mol Biol Rep</source> <year>2012</year>; <volume>39</volume>: <fpage>2081</fpage>–<lpage>2087</lpage>.</citation></ref>
<ref id="bibr47-0300060513475570"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Canter</surname><given-names>JA</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Spencer</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Mitochondrial DNA polymorphism A4917G is independently associated with age-related macular degeneration</article-title>. <source>PLoS One</source> <year>2008</year>; <volume>3</volume>: <fpage>e2091</fpage>–<lpage>e2091</lpage>.</citation></ref>
<ref id="bibr48-0300060513475570"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>N</given-names></name><name><surname>Bessho</surname><given-names>H</given-names></name><name><surname>Honda</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Complement factor H Y402H variant and risk of age-related macular degeneration in Asians: a systematic review and meta-analysis</article-title>. <source>Ophthalmology</source> <year>2011</year>; <volume>118</volume>: <fpage>339</fpage>–<lpage>344</lpage>.</citation></ref>
<ref id="bibr49-0300060513475570"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>KL</given-names></name><name><surname>Olson</surname><given-names>LM</given-names></name><name><surname>Anderson</surname><given-names>BM</given-names></name><etal/></person-group>. <article-title>C3 R102G polymorphism increases risk of age-related macular degeneration</article-title>. <source>Hum Mol Genet</source> <year>2008</year>; <volume>17</volume>: <fpage>1821</fpage>–<lpage>1824</lpage>.</citation></ref>
<ref id="bibr50-0300060513475570"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis</article-title>. <source>Mol Vis</source> <year>2010</year>; <volume>16</volume>: <fpage>1958</fpage>–<lpage>1981</lpage>.</citation></ref>
<ref id="bibr51-0300060513475570"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>NP</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>HTRA1 promoter polymorphism and risk of age-related macular degeneration: a meta-analysis</article-title>. <source>Ann Epidemiol</source> <year>2009</year>; <volume>19</volume>: <fpage>740</fpage>–<lpage>745</lpage>.</citation></ref>
<ref id="bibr52-0300060513475570"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Tao</surname><given-names>Q</given-names></name><etal/></person-group>. <article-title>Meta-analysis of the association of the HTRA1 polymorphisms with the risk of age-related macular degeneration</article-title>. <source>Exp Eye Res</source> <year>2009</year>; <volume>89</volume>: <fpage>292</fpage>–<lpage>300</lpage>.</citation></ref>
<ref id="bibr53-0300060513475570"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>C</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>CFB/C2 Gene polymorphisms and risk of age-related macular degeneration: a systematic review and meta-analysis</article-title>. <source>Curr Eye Res</source> <year>2012</year>; <volume>37</volume>: <fpage>259</fpage>–<lpage>271</lpage>.</citation></ref>
<ref id="bibr54-0300060513475570"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>AE</given-names></name><name><surname>Mullan</surname><given-names>GM</given-names></name><name><surname>Bradley</surname><given-names>DT</given-names></name></person-group>. <article-title>Complement factor B polymorphism 32W protects against age-related macular degeneration</article-title>. <source>Mol Vis</source> <year>2011</year>; <volume>17</volume>: <fpage>983</fpage>–<lpage>988</lpage>.</citation></ref>
</ref-list>
</back>
</article>